# Out-of-office Monitoring for Rhythms Of Normal Versus Atrial Fibrillation

Study · id `cardio:ct-nct07582523` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07582523](<https://clinicaltrials.gov/study/NCT07582523>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07582523

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: High blood pressure; Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 1910 participants.

## Technical summary

Registry record NCT07582523. Randomized; no masking; primary purpose screening. Start 2026-04-01 (actual); primary completion 2029-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 1910 participants (planned count; ClinicalTrials.gov record NCT07582523, source copy `cardio:ctgov-nct07582523-2026-05-13`, retrieved 2026-10-26)
- Started: 2026-04-01 (actual) (ClinicalTrials.gov record NCT07582523, source copy `cardio:ctgov-nct07582523-2026-05-13`, retrieved 2026-10-26)
- Primary completion: 2029-04 (anticipated) (ClinicalTrials.gov record NCT07582523, source copy `cardio:ctgov-nct07582523-2026-05-13`, retrieved 2026-10-26)
- Completion: 2029-04 (anticipated) (ClinicalTrials.gov record NCT07582523, source copy `cardio:ctgov-nct07582523-2026-05-13`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07582523, source copy `cardio:ctgov-nct07582523-2026-05-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07582523-2026-05-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Out-of-office Monitoring for Rhythms Of Normal Versus Atrial Fibrillation
- Acronym: OMRON-AF
- Condition: Atrial Fibrillation (AF)
- Condition: Hypertension (HTN)
- Condition: High Blood Pressure
- Intervention (Device): Blood Pressure Monitor Without AFib Detection
- Intervention (Device): Blood Pressure Monitor With AFib Detection
- Lead sponsor: University of California, San Francisco
- Lead sponsor class: OTHER
- Collaborator: Omron Healthcare Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University of California, San Francisco (`cardio:org-university-of-california-san-francisco`)

## Provenance

Content hash: d1778c6086debd820f1d83c3b23f2286edf32d4b113e38e392a75a4561c0dc27
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
